Mark Harries Selected Research

Mark Harries Research Topics

Disease

16	Melanoma (Melanoma, Malignant) 01/2022 - 12/2007
9	Neoplasms (Cancer) 01/2022 - 04/2011
8	Breast Neoplasms (Breast Cancer) 04/2019 - 08/2005
4	Disease Progression 01/2022 - 04/2011
4	Neoplasm Metastasis (Metastasis) 04/2019 - 05/2014
2	Brain Neoplasms (Brain Tumor) 10/2015 - 01/2013
2	Ovarian Epithelial Carcinoma 09/2002 - 09/2002
2	Ovarian Neoplasms (Ovarian Cancer) 09/2002 - 09/2002
1	COVID-19 01/2021
1	Cardiotoxicity 01/2019
1	Triple Negative Breast Neoplasms 01/2018
1	Pathologic Complete Response 07/2014
1	Drug-Related Side Effects and Adverse Reactions 05/2014
1	Erectile Dysfunction 05/2014
1	Hypertension (High Blood Pressure) 05/2014
1	Optic Neuritis (Retrobulbar Neuritis) 05/2014
1	Inflammation (Inflammations) 04/2013
1	Carcinoma (Carcinomatosis) 09/2012
1	Renal Cell Carcinoma (Grawitz Tumor) 04/2011
1	Fatigue 04/2011
1	Fever (Fevers) 04/2011
1	Chills 04/2011
1	Headache (Headaches) 04/2011
1	Vomiting 04/2011
1	Lobular Carcinoma 08/2010
1	Metabolic Diseases (Metabolic Disease) 12/2007
1	Hodgkin Disease (Hodgkin's Disease) 03/2003
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2003
1	Lymphoma (Lymphomas) 03/2003

Drug/Important Bio-Agent (IBA)

5	Immunoglobulin G (IgG)IBA 01/2021 - 04/2011
4	AntibodiesIBA 01/2016 - 04/2011
3	Monoclonal AntibodiesIBA 01/2018 - 04/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 04/2013
3	AnthracyclinesIBA 07/2014 - 12/2006
3	Biomarkers (Surrogate Marker)IBA 04/2013 - 12/2007
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2011
2	Trastuzumab (Herceptin)FDA Link 01/2019 - 08/2005
2	Bevacizumab (Avastin)FDA Link 01/2018 - 05/2014
2	InterferonsIBA 05/2017 - 04/2011
2	IpilimumabIBA 10/2015 - 01/2013
2	Taxoids (Taxanes)IBA 02/2014 - 09/2002
2	Gemcitabine FDA Link 02/2014 - 03/2003
2	Estrogen ReceptorsIBA 09/2012 - 08/2010
2	Albumin-Bound Paclitaxel FDA Link 01/2006 - 11/2005
1	Cell-Free Nucleic AcidsIBA 01/2022
1	N 30IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	VaccinesIBA 01/2021
1	COVID-19 VaccinesIBA 01/2021
1	BNT162 VaccineIBA 01/2021
1	Sodium Fluoride (Ossin)FDA Link 04/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2019
1	FluoridesIBA 04/2019
1	Messenger RNA (mRNA)IBA 01/2018
1	Trinitrotoluene (TNT)IBA 01/2018
1	PlatinumIBA 01/2018
1	Carboplatin (JM8)FDA LinkGeneric 01/2018
1	AntigensIBA 01/2016
1	Immunoglobulins (Immunoglobulin)IBA 11/2015
1	AlbuminsIBA 10/2015
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2015
1	taxaneIBA 07/2014
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2014
1	Epirubicin (Ellence)FDA LinkGeneric 02/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2014
1	Neoplasm Antigens (Tumor Antigens)IBA 04/2013
1	Interleukin-10 (Interleukin 10)IBA 04/2013
1	Interleukin-4 (Interleukin 4)IBA 04/2013
1	VemurafenibIBA 01/2013
1	dabrafenibIBA 01/2013
1	Tamoxifen FDA LinkGeneric 09/2012
1	Pharmaceutical PreparationsIBA 04/2011
1	CytokinesIBA 04/2011
1	Transaminases (Aminotransferases)IBA 04/2011
1	Interleukin-12 (IL 12)IBA 04/2011
1	Fibronectins (Fibronectin)IBA 04/2011
1	Docetaxel (Taxotere)FDA Link 12/2006
1	Methylprednisolone FDA LinkGeneric 03/2003
1	Cisplatin (Platino)FDA LinkGeneric 03/2003
1	Platinum Compounds (Compounds, Platinum)IBA 09/2002
1	Cytotoxins (Cytolysins)IBA 09/2002

Therapy/Procedure

7	Therapeutics 04/2019 - 12/2007
7	Drug Therapy (Chemotherapy) 01/2019 - 09/2002
3	Neoadjuvant Therapy 07/2014 - 08/2010
1	Radiotherapy 01/2022
1	Emergency Treatment 12/2017
1	Injections 10/2016
1	Immunotherapy 01/2016
1	Salvage Therapy 03/2003